Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help ...

On Monday, Aclarion Inc (ACON) stock saw a decline, ending the day at $0.04 which represents a decrease of $-0.01 or -20.00% from the prior close of $0.05. The stock opened at $0.04 and touched a low ...

Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help ...

BROOMFIELD, CO - Aclarion, Inc. (NASDAQ:ACON, ACONW), a healthcare technology company with a current market capitalization of ...

In a stark reflection of investor sentiment, Aclarion Inc. (ACON) stock has plummeted to a 52-week low, trading at a mere ...

Comparatively, Aclarion has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500. Aclarion has a consensus price target of $1.30, indicating a potential upside of ...

ACON Stock Performance and Moving Averages. In recent trading, Aclarion Inc (ACON) stock price has shown some volatility, fluctuating 1.65% over the last five trades and -62.30% o ...

Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to ...

The Nasdaq could face market-cap losses of nearly $1 trillion if premarket declines hold into the close of trading.